CBLL
CeriBell, Inc. · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth +30.0% ·
share flow +30.0% ·
net new positions +20.0%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Millennium Management ✦ | 503.69K | New | $13.04M | 0.0% | New | 1 | SEC ↗ |
| 2 | Adage Capital Partners ✦ | 318.07K | New | $8.23M | 0.0% | New | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 257.07K | New | $6.65M | 0.0% | New | 1 | SEC ↗ ×2 |
| 4 | Citadel Advisors ✦ | 206.35K | New | $5.34M | 0.0% | New | 1 | SEC ↗ ×2 |
| 5 | State Street Global Advisors ✦ (passive) | 154.99K | — | $4.01M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Renaissance Technologies ✦ | 41.90K | New | $1.08M | 0.0% | New | 1 | SEC ↗ |
| 7 | Marshall Wace ✦ | 31.21K | New | $807,844 | 0.0% | New | 1 | SEC ↗ |
| 8 | Soros Fund Management ✦ | 25.00K | New | $647,000 | 0.0% | New | 1 | SEC ↗ |
| 9 | Norges Bank ✦ (passive) | 16.32K | New | $422,258 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Millennium Management | $13.04M | 0.0% |
| Adage Capital Partners | $8.23M | 0.0% |
| Geode Capital Management | $6.65M | 0.0% |
| Citadel Advisors | $5.34M | 0.0% |
| Renaissance Technologies | $1.08M | 0.0% |
| Marshall Wace | $807,844 | 0.0% |
| Soros Fund Management | $647,000 | 0.0% |
| Norges Bank | $422,258 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 121 holders, 29.58M shares, $536.67M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 4.89K sh · $119,145
Officer, Director · 20.85K sh · $521,775
Officer · 846 sh · $21,150
Officer · 7.50K sh · $181,875
Officer · 1.75K sh · $42,576
Officer · 4.89K sh · $118,901
Officer · 652 sh · $16,300
Officer, Director · 39.54K sh · $973,079
Officer · 859 sh · $20,573
Officer, Director · 6.07K sh · $145,753
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology